Lv2
120 积分 2023-07-04 加入
Microfluidic-based platforms for cell-to-cell communication studies
1天前
已完结
中国重症肌无力诊断和治疗指南（2025版）
1个月前
已完结
Association of British Neurologists (ABN) autoimmune myasthenia gravis management guidelines (2025 update)
1个月前
已完结
Synthetic and Natural Radioprotective Agents: Recent Status and their Underlying Mechanism of Action
2个月前
已完结
Repurposing of Various Current Medicines as Radioprotective Agents
2个月前
已完结
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer
11个月前
已完结
Radiotherapy plus camrelizumab and irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial
11个月前
已完结
Clinical and genetic characteristics of patients with TRG 0 and TRG III in esophageal squamous cell carcinoma after neoadjuvant therapy
11个月前
已完结
An Open‐Label Phase II Trial of Pembrolizumab, an Immune Checkpoint Inhibitor Alone or in Combination With Oral Azacitidine as Second‐Line Therapy for Advanced Head and Neck Squamous Cell Cancers
11个月前
已完结
Predicting EGFR and PD-L1 Status in NSCLC Patients Using Multitask AI System Based on CT Images
皖公网安备34019202002308
